Abstract

Advanced Compounding: Compounding with Microneedle Arrays, Part 3: Microneedle Array Development in the Literature and Quality Control of Microneedle Arrays

Author(s): Allen Loyd V Jr

Issue: Jan/Feb 2023 - Volume 27, Number 1

Page(s): 30-37

Download in electronic PDF format for $75
  • Advanced Compounding: Compounding with Microneedle Arrays, Part 3: Microneedle Array Development in the Literature and Quality Control of Microneedle Arrays Page 1
  • Advanced Compounding: Compounding with Microneedle Arrays, Part 3: Microneedle Array Development in the Literature and Quality Control of Microneedle Arrays Page 2
  • Advanced Compounding: Compounding with Microneedle Arrays, Part 3: Microneedle Array Development in the Literature and Quality Control of Microneedle Arrays Page 3
  • Advanced Compounding: Compounding with Microneedle Arrays, Part 3: Microneedle Array Development in the Literature and Quality Control of Microneedle Arrays Page 4
  • Advanced Compounding: Compounding with Microneedle Arrays, Part 3: Microneedle Array Development in the Literature and Quality Control of Microneedle Arrays Page 5
  • Advanced Compounding: Compounding with Microneedle Arrays, Part 3: Microneedle Array Development in the Literature and Quality Control of Microneedle Arrays Page 6
  • Advanced Compounding: Compounding with Microneedle Arrays, Part 3: Microneedle Array Development in the Literature and Quality Control of Microneedle Arrays Page 7
  • Advanced Compounding: Compounding with Microneedle Arrays, Part 3: Microneedle Array Development in the Literature and Quality Control of Microneedle Arrays Page 8

Abstract

Microneedle arrays, or microneedle array patches (terms are often used interchangeably), are promising devices for the transdermal delivery of drugs and vaccines. Unique microneedle arrays can be prepared from various materials and can be either solid or hollow. Upon insertion, they rapidly take up skin interstitial fluid to form continuous, open conduits from the attached patch-type drug reservoirs to the dermal microcirculation. Microneedle array patches can be prepared using molds in a wide range of patch sizes and microneedle geometries, can be easily sterilized, resist hole closure while in place, and are removed completely intact from the skin. Delivery of macromolecules is no longer limited to what can be loaded into the microneedles themselves, as they can also be loaded as a reservoir and delivered through the microneedles. Also, transdermal drug delivery can now be controlled by the cross-linked density of the hydrogel matrix rather than the stratum corneum. This newer technology has the potential to overcome limitations of conventional microneedle designs and to greatly increase the range of the type of drug that is deliverable transdermally, which benefits industry, healthcare providers, and, ultimately, patients.

Related Keywords

  • microneedle arrays
  • microneedle array patches
  • transdermal drug delivery
  • transdermal vaccine delivery
  • intradermal drug delivery
  • drug reservoir
  • safety
  • adverse effects
  • skin irritation
  • microneedle array product development
  • curcumin
  • esketamine
  • hydrogel-forming microneedle arrays
  • tofacitinib citrate
  • autoimmune-mediated inflammatory skin diseases
  • vancomycin
  • solubility in water
  • 3D printing
  • polymeric microneedle arrays
  • sugar-based microneedle arrays
  • manufacturing processes
  • manufacturing technology
  • biocompatibility
  • polymer materials
  • photolithography
  • replica molding
  • quality control
  • parafilm insertion test
  • macromolecule delivery

Related Categories

  • TECHNOLOGY
  • QUALITY CONTROL
  • ADVERSE DRUG EVENTS
  • DOSAGE FORMS/DRUG CARRIERS
  • LITERATURE REVIEW

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Jan/Feb 2023
Pg. 30-37
Advanced Compounding: Compounding with Microneedle Arrays, Part 3: Microneedle Array Development in the Literature and Quality Control of Microneedle Arrays
Author(s): Allen Loyd V Jr
Nov/Dec 2022
Pg. 490-495
Compounding with Microneedle Arrays, Part 2: Preparation and Administration Methods
Author(s): Allen Loyd V Jr
Sep/Oct 2022
Pg. 400-408
Basics of Compounding: Compounding with Microneedle Arrays, Part 1: Introduction and Overview
Author(s): Allen Loyd V Jr
Mar/Apr 2003
Pg. 106-113
Veterinary Transdermal Medications: A to Z
Author(s): Davidson Gigi S
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Sep/Oct 2022
Pg. 356
PreScription: A New Dosage Form
Author(s): Allen Loyd V Jr
Jan/Feb 2012
Pg. 62-63
The Use of Pluronic Lecithin Organogels in the Transdermal Delivery of Drugs
Author(s): Bramwell Bethany L, Williams LaVonn A
Jul/Aug 2004
Pg. 269-274
Current Topical Treatments in Wound Healing - Part 1
Author(s): Helmke Christopher D
Mar/Apr 2015
Pg. 152-160
Transdermal Delivery of Nisoldipine: Refinement of Vehicles
Author(s): El Maghraby Gamal M, Ahmed Amal A, Osman Mohamed A
Nov/Dec 2015
Pg. 491-500
Basics of Sterile Compounding: Sterile Product Packaging and Delivery Systems
Author(s): Akers Michael J
Nov/Dec 2015
Pg. 453-463
Applying Quality of Design Concepts to Pharmacy Compounding
Author(s): Timko Robert J
Jan/Feb 2019
Pg. 65-69
Transdermal Delivery of Metformin Hydrochloride from a Semisolid Vehicle
Author(s): Polonini Hudson, Lopes Cândido Paulo José, Andrade Junquiera Laura, Loures Sharlene, Raposo Nádia RB, Fernandes Brandão Marcos Antônio, de Oliveira Ferreira Anderson
Jan/Feb 2020
Pg. 30-36
Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs
Author(s): Dillon L R
Mar/Apr 2015
Pg. 121-124
Quality Assurance and Quality Control, Part 1
Author(s): Akers Michael J
Jul/Aug 2005
Pg. 300-302
Quality-Control Analytical Methods: Glossary of Quality Control/Quality Assurance Terms in Pharmaceutical Compounding
Author(s): Kupiec Thomas C, Okeke Claudia, Allen Loyd V Jr, Denison Clay
Jul/Aug 2006
Pg. 281-284
Quality Control Analytical Methods: A Guide to Quality Control Testing for the Compounding Pharmacist
Author(s): Zolner William J
Jan/Feb 2014
Pg. 6-12
The Role of Compounding in Closing Therapeutic Gaps--Abstracts from FIP 2013
Author(s): Lutz Eugene, Pauletti Giovanni, Carvalho Maria, Davidson Gigi, Ashworth Lisa, Subramaniam Vaiyapuri, Llambí Francesc
Sep/Oct 2009
Pg. 412-418
Quality-Control Analytical Methods: Designing a Quality-Control Potency Testing Program for a Compounding Pharmacy
Author(s): Zolner William J
May/Jun 2015
Pg. 215-221
Quality Assurance and Quality Control, Part 2
Author(s): Akers Michael J
Sep/Oct 2014
Pg. 366-369
To Compound or Not to Compound: A Veterinary Transdermal Discussion
Author(s): Eichstadt Lauren R, Davidson Gigi S